Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers

Sleep Disorder, Shift-Work Clinical Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to test the hypothesis that ingestion of the wake-inhibiting drug suvorexant 30 minutes prior to daytime sleep initiation in individuals working overnight shifts will significantly improve both objective (total sleep time, sleep efficiency, wake after sleep onset) and subjective (sleep quality) measures of daytime sleep.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Sleep Disorder, Shift-Work
• Sleep Disorders, Circadian Rhythm
• Sleep Wake Disorders

• NCT number: NCT02491788
• Study type: Interventional
• Source: VA Palo Alto Health Care System
• Status: Completed
• Phase: Phase 4
• Start date: February 1, 2016
• Completion date: August 1, 2019